期刊文献+

骨髓间充质干细胞移植与肾脏病 被引量:1

Bone Marrow Mesenchymal Stem Cell Transplantation for Kidney Disease
原文传递
导出
摘要 骨髓间充质干细胞是目前广受关注的一群成体干细胞,具有取材容易,增殖能力强,生物学特性稳定,可以跨胚层分化,低免疫源性,参与受损组织修复等优点,随着组织工程的兴起和发展以及其自身所特有的生物学特性,人们逐渐认识到将骨髓间充质干细胞作为肾脏病移植治疗的种子细胞具有良好的应用前景。本文就骨髓间充质干细胞的生物学特性及其在肾脏病移植治疗中的进展做一综述。 Bone marrow mesenchymal stem cells (MSCs) are a population of adult stem cells and have many advantages, e.g. they are easily available, have high proliferation capability, characteristics of biology are stable, have the potential of multidirectional differentiation, their immunogenicity is lower and participate in repairing functional tissue after injury. With the rise and development of tissue engineering, as well as their own characteristics of biology, people gradually realize that it has potential clinical application to use bone marrow mesenchymal stem cells as seed cells transplatation in the treatment of kidney diseases. The essay is to review the biologic characteristics and application prospects of MSCs in transplantation for kidney disease.
出处 《现代生物医学进展》 CAS 2011年第10期1987-1990,共4页 Progress in Modern Biomedicine
基金 国家自然科学基金资助项目(30570871) 重庆市科委自然科学基金项目(CSTC 2007BB5017)
关键词 间充质干细胞 肾脏病 移植 Mesenchymal stem cell Kidney disease Transplantation
  • 相关文献

参考文献5

  • 1Singaravelu K, Padanilarn BJ. In vitro differentiation of MSC into cells with a renal tubular epithelial-like phenotype [J]. Ren Fail, 2009, 31 (6): 492-502.
  • 2Rookmaaker MB, Smits AM, Tolboom H, et al. Bone-marrow-derived cells contribute to glomerular endothelial repair in experimental glomerulonephritis[J]. Am J Pathol, 2003,163(2):553-562.
  • 3Anjos-Afunso F, Siapati EK, Bonnet D. In vivo contribution of murine mesenchymal stem cells into multiple cell-types under minimal damage conditions[J]. J Cell Sci, 2004,117(Pt 23): 5655-5664.
  • 4Friedenstein AJ, Gorskaja JF, Kulagina NN. Fibroblast precursors in normal and irradiated mouse hematopoietic organs [J]. Exp Hematol, 1976,4(5):267-274.
  • 5项舟,胡炜,孔清泉,周海涛,张喜海.骨髓间充质干细胞种植Ⅰ型胶原支架材料修复关节软骨缺损的初步研究(英文)[J].中国修复重建外科杂志,2006,20(2):148-154. 被引量:18

二级参考文献30

  • 1Caplan AI. Mesenchymal stem cells.J Orthop Res, 1991,9(5) :641-650.
  • 2Prockop DJ. Marrow stromal cells as stem cells for nonhematopoietic tissues. Science, 1997,276 ( 5309 ) : 71-74.
  • 3Grigoriadis AE, Heersche JN, Aubin JE. Differentiation of muscle, fat, cartilage, and bone from progenitor cells present in a bone-derived clonal cell population: effect of dexamethasone. J Cell Biol, 1988, 106 (6): 2139-2151.
  • 4Calvert JW, Marra KG, Cook L, et al. Characterization of osteoblast-like behavior of cultured bone marrow stromal cells on various polymer surfaces. J Biomed Mater Res,2000,52(2) :279-284.
  • 5Wakitani S, Goto T, Pineda SJ, et al. Mesenchymal cell-based repair of large, full-thickness defects of articular cartilage. J Bone Joint Surg (Am),1994,76(4) :579-592.
  • 6Ponticiello MS, Schinagi RM, Kadiyala S, et al. Gelatin-based resorbable sponge as a carrier matrix for human mesenchymal stem cells in cartilage regeneration therapy.J Biomed Mater Res,2000,52(2):246-255.
  • 7Young RG, Butler DL, Weber W, et al. Use of mesenchymal stem cells in a collagen matrix for Achilles tendon repair. J Orthop Res, 1998,16(4) :406-413.
  • 8Breinan HA, Martin SD, Hsu HP, et al. Healing of canine articular cartilage defects treated with microfracture, a type-Ⅱ collagen matrix,or cultured autologous chondrocytes.J Orthop Res,2000,18(5) :781-789.
  • 9Johnstone B, Hering TM, Caplan AI, et al. In vitro chondrogenesis of bone marrow-derived mesenchymal progenitor cells. Exp Cell Res, 1998, 238(1):265-272.
  • 10Kinner B,Zaleskas JM, Spector M. Regulation of smooth muscle actin expression and contraction in adult human mesenchymal stem cells. Exp Cell Res, 2002,278 ( 1 ) : 72-83.

共引文献17

同被引文献14

  • 1Zhang L, Wang F, Wang L, et al. Prevalence of chronic kidney dis- ease in China: a cross-sectional survey [ J ]. Lancet, 2012, 379 (9818) :815 -822.
  • 2Choi S,Park M,Kim J,et al. The role of mesenchymal stem cells in the functional improvement of chronic renal failure [ J ]. Stem Cells Dev,2009,18(3) :521 -529.
  • 3Semedo P,Correa-Costa M, Antonio Cenedeze M, et al. Mesenehymal stem cells attenuate renal fibrosis through immune modulation and remodeling properties in a ratremnant kidney model[ J ]. Stem Cells, 2009,27 (12) :3063 - 3073.
  • 4Zonta S,De Martino M, Bedino G, et al. Which is the most suitable and effective route of administration for mesenchymal stem cell-based immunomodulation therapy in experimental kidney transplantation: endovenous or arterial? [ J ]. Transplant Proc, 2010,42 ( 4 ) : 1336 - 1340.
  • 5Yoo JH,Park C, Jung DI,et al. In vivo cell tracking of canine allo- genic mesenchymal stem cells administration via renal arterial cathe- terlzation and physiopathologieal effects on the kidney in two healthy dogs[ J]. J Vet Med Sci,2011,73(2) :269 -274.
  • 6Alharazy SM, Kong N, Saidin R, et al. Neutrophil gelatinase-associat- ed lipocalin as an early marker of contrast-induced nephropathy after coronary angiography [ J ]. Angiology ,2014,65 ( 3 ) : 216 - 223.
  • 7胡世兵,须可扬,李树春,孙毓花,顾建平.超选择性肾动脉栓塞治疗肾脏损伤出血的临床应用[J].中国临床研究,2011,24(1):18-20. 被引量:8
  • 8赵桂锋,纪莲,Perry刘.由左颈总动脉导管经肾动脉的大鼠肾脏无创伤给药法探讨[J].中国比较医学杂志,2011,21(9):37-39. 被引量:2
  • 9李雪,李德天,张蓓茹.造影剂引起急性肾损伤及死亡危险因素分析[J].中国实用内科杂志,2013,33(1):42-45. 被引量:19
  • 10杨妍姣,丁峰.造影剂致急性肾损伤的研究进展[J].中国血液净化,2013,12(1):4-7. 被引量:7

引证文献1

二级引证文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部